XML 28 R16.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

3 Months Ended

Apr. 30, 2022

(10) Stock-Based Compensation

Stock-Based Compensation

During the 13 weeks ended April 30, 2022 the Company recognized total stock-based compensation expense of $1,358. During the 13 weeks ended May 1, 2021, the Company recognized total stock-based compensation expense of $1,016. Compensation expense related to the Company's stock-based payment awards is recognized in selling, general, and administrative expenses in the condensed consolidated statements of operations.

Employee Stock Plans

As of April 30, 2022, the number of shares available for awards under the 2019 Performance Incentive Plan (the “2019 Plan”) was 1,626. As of April 30, 2022, there were 1,389 unvested stock awards outstanding under the 2019 Plan.

Employee Stock Purchase Plan

The Company also has an Employee Stock Purchase Plan (“ESPP”) that was approved by shareholders in fiscal year 2015, under which 800 shares of common stock were authorized. For the 13 weeks ended April 30, 2022, no shares were issued under the ESPP and, as of April 30, 2022, the number of shares available for issuance was 374.

Nonvested Performance-Based Stock Awards

During the 13 weeks ended April 30, 2022, the Company issued 141 nonvested performance-based stock awards to employees at a weighted average grant date fair value of $11.29 per share. The nonvested performance-based stock awards issued to employees vest in full on the third anniversary of the grant date. The number of shares issued is contingent on management achieving fiscal year 2022, 2023, and 2024 performance targets for total revenue growth and adjusted EPS. If minimum threshold performance targets are not achieved, no shares will vest. The maximum number of shares subject to the award is 282, and the “target” number of shares subject to the award is 141 as reported below. Following the end of the performance period (fiscal years 2022, 2023, and 2024), the number of shares eligible to vest, based on actual performance, will be fixed and vesting will then be subject to each employee’s continued employment over the remaining service period.

During the 13 weeks ended May 1, 2021, the Company did not issue any nonvested performance-based stock awards.

The following table sets forth the rollforward of outstanding nonvested performance-based stock awards (per share amounts are not in thousands):


		Weighted
		average
		grant-date
	Shares	fair value
Balance at January 29, 2022	487	$	5.13
Grants	141		11.29
Forfeitures	(39)		5.63
Vested	(168)		3.49
Balance at April 30, 2022	421	$	7.81

		Weighted
		average
		grant-date
	Shares	fair value
Balance at January 30, 2021	624	$	5.13
Grants	—		—
Forfeitures	(13)		5.63
Vested	(22)		4.91
Balance at May 1, 2021	589	$	5.13

Nonvested Stock Unit Awards

During the 13 weeks ended April 30, 2022, the Company issued 308 nonvested stock units, respectively, to employees of the Company at an average value of $11.28 per share. The shares issued to employees of the Company vest over a three-year period with one third of the shares vesting on each grant date anniversary.

During the 13 weeks ended May 1, 2021, the Company issued 221 nonvested stock units to employees of the Company at an average value of $17.27 per share. The shares issued to employees of the Company vest over a three year period with one third of the shares vesting on each grant date anniversary.

The following table sets forth the rollforward of outstanding nonvested stock units (per share amounts are not in thousands):


		Weighted
		average
		grant-date
	Shares	fair value
Balance at January 29, 2022	929	$	11.56
Grants	308		11.28
Forfeitures	(21)		11.70
Vested	(248)		7.96
Balance at April 30, 2022	968	$	12.39

		Weighted
		average
		grant-date
	Shares	fair value
Balance at January 30, 2021	779	$	5.19
Grants	221		17.27
Forfeitures	(18)		7.33
Vested	(303)		5.05
Balance at May 1, 2021	679	$	9.15